CG
INO icon

Cutler Group’s Inovio Pharmaceuticals INO Stock Holding History

Cutler Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-58
Closed -$1K – 4239
2022
Q4 		$1K Sell
58
-67
-54% -$1.52K ﹤0.01% 4044
2022
Q3 		$2K Buy
125
+75
+150% +$1.92K ﹤0.01% 4217
2022
Q2 		$1K Buy
50
+17
+52% +$479 ﹤0.01% 4616
2022
Q1 		$1K Sell
33
-3,137
-99% -$141K ﹤0.01% 4992
2021
Q4 		$189K Buy
3,170
+2,970
+1,485% +$238K 0.01% 1368
2021
Q3 		$17K Sell
200
-42
-17% -$4.21K ﹤0.01% 3491
2021
Q2 		$26K Hold
242
– – ﹤0.01% 3074
2021
Q1 		$26K Sell
242
-44
-15% -$5.79K ﹤0.01% 2976
2020
Q4 		$30K Buy
286
+178
+165% +$23.7K ﹤0.01% 2363
2020
Q3 		$15K Sell
108
-117
-52% -$24.4K ﹤0.01% 2695
2020
Q2 		$72K Buy
225
+14
+7% +$2.25K ﹤0.01% 1499
2020
Q1 		$18K Buy
+211
New +$13K ﹤0.01% 2370
2018
Q2 		– Sell
-25
Closed -$1K – 4500
2018
Q1 		$1K Sell
25
-8
-24% -$433 ﹤0.01% 4061
2017
Q4 		$1K Sell
33
-355
-91% -$22K ﹤0.01% 4474
2017
Q3 		$29K Sell
388
-130
-25% -$9.67K ﹤0.01% 2771
2017
Q2 		$48K Buy
+518
New +$44.3K ﹤0.01% 2540
2017
Q1 		– Sell
-300
Closed -$23.9K – 6754
2016
Q4 		$24K Buy
300
+25
+9% +$2.26K ﹤0.01% 3275
2016
Q3 		$30K Sell
275
-50
-15% -$5.52K ﹤0.01% 3006
2016
Q2 		$35K Sell
325
-273
-46% -$33.2K ﹤0.01% 2732
2016
Q1 		$62K Sell
598
-798
-57% -$61.6K ﹤0.01% 2096
2015
Q4 		$112K Buy
+1,396
New +$111K 0.01% 1653

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's INO Position: Q1 2023 in Review

Cutler Group sold out of Inovio Pharmaceuticals (INO) in Q1 2023, closing a stake of 58 shares — an estimated $1K sold.

Cutler Group first reported a position in INO in Q4 2015 and held it in 21 quarters. The position peaked at $189K in Q4 2021. 174 funds tracked by Wall St. Rank hold INO as of Q1 2023.

  • Cutler Group reported no remaining Inovio Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 58 Inovio Pharmaceuticals shares in Q1 2023, an estimated $1K.
  • Cutler Group first reported a position in Inovio Pharmaceuticals in Q4 2015 and held it in 21 quarters.
  • Cutler Group's Inovio Pharmaceuticals position peaked at $189K in Q4 2021.
  • 174 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.